Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters
Type of study
Language
Document Type
Year range
1.
New-onset atypical fulminant type 1 diabetes after COVID-19 vaccination: A case report.
Kobayashi, Takaaki; Yakou, Fumiyoshi; Saburi, Masuo; Hirose, Ai; Akaoka, Hiroaki; Hirota, Yusuke; Yunaiyama, Daisuke; Asahi, Nobuteru; Ohno, Atsushi; Matsushita, Takaya.
Clin Case Rep ; 10(10): e6473, 2022 Oct.
Article in English | MEDLINE | ID: covidwho-2127617

ABSTRACT

Adverse reactions, including the onset of diabetes, after coronavirus disease 2019 (COVID-19) vaccination have been reported. Herein, we report a case of a man who developed anti-glutamic acid decarboxylase (GAD) antibody-positive fulminant type 1 diabetes 15 weeks after COVID-19 vaccination, atypical of the previously reported anti-GAD antibody-negative cases.

2.
New‐onset atypical fulminant type 1 diabetes after COVID‐19 vaccination: A case report
Kobayashi, Takaaki, Yakou, Fumiyoshi, Saburi, Masuo, Hirose, Ai, Akaoka, Hiroaki, Hirota, Yusuke, Yunaiyama, Daisuke, Asahi, Nobuteru, Ohno, Atsushi, Matsushita, Takaya.
Clinical case reports ; 10(10), 2022.
Article in English | EuropePMC | ID: covidwho-2073283

ABSTRACT

Adverse reactions, including the onset of diabetes, after coronavirus disease 2019 (COVID‐19) vaccination have been reported. Herein, we report a case of a man who developed anti‐glutamic acid decarboxylase (GAD) antibody‐positive fulminant type 1 diabetes 15 weeks after COVID‐19 vaccination, atypical of the previously reported anti‐GAD antibody‐negative cases.

SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL